Skip to main content
. Author manuscript; available in PMC: 2017 Jan 4.
Published in final edited form as: Neuromuscul Disord. 2014 Feb 14;24(5):453–462. doi: 10.1016/j.nmd.2014.02.002

Fig. 1.

Fig. 1

(a) Scheme presenting the FHL1 gene, mRNA and protein isoforms and the localization of the different FHL1 mutations giving ride to different myopathies. (b) Typical structure of reducing bodies revealed by menadione–NBT staining; and (c) by electronic microscopy.